The research, spearheaded by Prof. Dr. H. Seda Vatansever and presented by Dr. Faika Başoğlu, showcased the results, earning the team, including Assoc. Prof. Dr. Eda Becer, Hilal Kabadayı Ensarioğlu, Prof. Dr. Nuray Ulusoy Güzeldemirci, and Ebru Didem Coşar, the esteemed “best oral presentation” award.
The newfound molecule, designed with inspiration from FDA-approved “Levamisole” and “Triapine,” possesses anticancer properties. Its synthesis in four efficient steps marked a significant breakthrough. Given the limited treatment options for liver cancer, the data obtained from this study are crucial for future drug designs. The researchers also explored eight molecules with similar structures in their investigation.
The potential applications of the new molecule extend beyond liver cancer, offering hope for treating various cancer types. The molecule’s inhibitory effects on liver cancer cells were particularly promising, prompting the research team to pursue further laboratory investigations on structurally similar molecules.
Researchers are dedicated to identifying additional molecules that could serve as guides for developing drugs targeting diverse cancers, including liver, breast, colon, and brain cancers. This pioneering research opens avenues for innovative cancer treatments, emphasizing the importance of ongoing efforts in the field.
More Information:
